Value For Money In The Treatment Of Patients With Type 2 Diabetes Mellitus: Assessing The Long-Term Cost-Effectiveness Of IDegLira Versus iGlarLixi In Italy

OBJECTIVE: Italian treatment guidelines for type 2 diabetes mellitus (T2DM) target good glycemic control but acknowledge the associated risk of hypoglycemia. Unlike traditional antidiabetic therapies, modern treatment options such as fixed-ratio combinations of basal insulin and glucagon-like peptid...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clinicoecon Outcomes Res
Päätekijät: Pöhlmann, Johannes, Montagnoli, Roberta, Lastoria, Giusi, Parekh, Witesh, Markert, Marie, Hunt, Barnaby
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Dove 2019
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6789179/
https://ncbi.nlm.nih.gov/pubmed/31632108
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S218746
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia